These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 19483750)
1. Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease. Manca-di-Villahermosa S; Taccone-Gallucci M; Maccarrone M Kidney Int; 2009 Jun; 75(12):1354-1355. PubMed ID: 19483750 [No Abstract] [Full Text] [Related]
2. Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease? Connor A; Tomson C BMJ; 2009 Aug; 339():b2949. PubMed ID: 19696089 [No Abstract] [Full Text] [Related]
9. Rosuvastatin in patients undergoing hemodialysis. de Oliveira JM N Engl J Med; 2009 Jul; 361(1):93-4; author reply 94-5. PubMed ID: 19579278 [No Abstract] [Full Text] [Related]
10. Statins in the prevention of cardiovascular events in patients with renal failure. Buemi M; Floccari F; Nostro L; Campo S; Caccamo C; Sturiale A; Aloisi C; Giacobbe MS; Frisina N Cardiovasc Hematol Disord Drug Targets; 2007 Mar; 7(1):7-13. PubMed ID: 17346123 [TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin in patients undergoing hemodialysis. Kassimatis TI; Konstantinopoulos PA N Engl J Med; 2009 Jul; 361(1):93; author reply 94-5. PubMed ID: 19579277 [No Abstract] [Full Text] [Related]
12. Statin use prolongs patient survival after renal transplantation. Ritz E; Wanner C J Am Soc Nephrol; 2008 Nov; 19(11):2037-40. PubMed ID: 18842988 [No Abstract] [Full Text] [Related]
13. Clinical implications of statin therapy in patients undergoing hemodialysis. Kim JJ; Langworthy DR; Hennessey EK Am J Health Syst Pharm; 2014 May; 71(9):703-10. PubMed ID: 24733132 [TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Seliger SL; Weiss NS; Gillen DL; Kestenbaum B; Ball A; Sherrard DJ; Stehman-Breen CO Kidney Int; 2002 Jan; 61(1):297-304. PubMed ID: 11786112 [TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin in patients undergoing hemodialysis. Ganguli A N Engl J Med; 2009 Jul; 361(1):93; author reply 94-5. PubMed ID: 19571292 [No Abstract] [Full Text] [Related]
16. Charting new territory by simulated modeling of a clinical trial. Tuttle KR Clin J Am Soc Nephrol; 2010 May; 5(5):750-2. PubMed ID: 20360306 [No Abstract] [Full Text] [Related]
17. Sunset for statins after AURORA? Strippoli GF; Craig JC N Engl J Med; 2009 Apr; 360(14):1455-7. PubMed ID: 19332454 [No Abstract] [Full Text] [Related]
18. Statin effects in CKD: is there a "point of no return"? Wanner C Am J Kidney Dis; 2009 May; 53(5):723-5. PubMed ID: 19393469 [No Abstract] [Full Text] [Related]
19. Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Sniderman AD; Solhpour A; Alam A; Williams K; Sloand JA Clin J Am Soc Nephrol; 2010 Feb; 5(2):335-40. PubMed ID: 20056762 [TBL] [Abstract][Full Text] [Related]
20. The role of chronic inflammation in cardiovascular mortality of uremic patients. Panichi V; Taccola D; Migliori M; Consani C; Giovannini L; Tetta C Int J Artif Organs; 2003 Jan; 26(1):12-8. PubMed ID: 12602464 [No Abstract] [Full Text] [Related] [Next] [New Search]